The calorie goal stays the same, but the delivery method adapts to what your GI system tolerates
Check your vial
In most rich countries semaglutide is still covered by patent protection at least until 2030 and possibly longerwhich means the foundation will be placed in the interesting position whereby its future wealth will be increasingly derived from the company it owns fighting patent battles in rich countries, and thereby limiting access to a life-saving drug
Authors: Thomas Kruse, Jakob Lerche Hansen, Kirsten Dahl, Lauge Schffer, Ulrich Sensfuss, Christian Poulsen, Morten Schlein, Ann Maria Kruse Hansen, Claus Bekker Jeppesen, Charlotta Dornonville de la Cour, Trine Ryberg Clausen, Eva Johansson, Simone Fulle, Rikke Bjerring Skyggebjerg, Kirsten Raun URL: This paper details the medicinal chemistry efforts that led to the design and synthesis of cagrilintide, a long-acting amylin analogue for the treatment of obesity
Tailoring GLP-1-coupled nutrition interventions to promote food sovereignty may help reduce disparities in diet-related diseases that persist among historically minoritized groups with strong cultural food traditions [242,243]
